| Q52681953 | "Kala-Azar is a Dishonest Disease": Community Perspectives on Access Barriers to Visceral Leishmaniasis (Kala-Azar) Diagnosis and Care in Southern Gadarif, Sudan. |
| Q47275946 | "The mosquitoes that destroy your face". Social impact of Cutaneous Leishmaniasis in South-eastern Morocco, A qualitative study |
| Q33528943 | A CATT negative result after treatment for human African trypanosomiasis is no indication for cure |
| Q49796018 | A Phase III Diagnostic Accuracy Study of a Rapid Diagnostic Test for Diagnosis of Second-Stage Human African Trypanosomiasis in the Democratic Republic of the Congo |
| Q30972586 | A comparative evaluation of the performance of commercially available rapid immunochromatographic tests for the diagnosis of visceral leishmaniasis in Bangladesh |
| Q38912949 | A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis |
| Q36338383 | A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis |
| Q24672110 | A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis |
| Q40500493 | A neglected disease of humans: a new focus of visceral leishmaniasis in Bakool, Somalia |
| Q54692892 | A new PCR-ELISA for diagnosis of visceral leishmaniasis in blood of HIV-negative subjects. |
| Q39052739 | A new format of the CATT test for the detection of human African Trypanosomiasis, designed for use in peripheral health facilities |
| Q28541690 | A screen-and-treat strategy targeting visceral leishmaniasis in HIV-infected individuals in endemic East African countries: the way forward? |
| Q36795545 | A survey on vaccine efficacy in the city of Bongor (Chad) and its operational consequences for the vaccination program |
| Q38580241 | A systematic review of the evidence that swimming pools improve health and wellbeing in remote Aboriginal communities in Australia |
| Q64137116 | Accuracy of a Rapid Diagnostic Test Based on Antigen Detection for the Diagnosis of Cutaneous Leishmaniasis in Patients with Suggestive Skin Lesions in Morocco |
| Q39510687 | Adherence to miltefosine treatment for visceral leishmaniasis under routine conditions in Nepal. |
| Q39196161 | An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia |
| Q56556829 | An application of Bayesian growth mixture modelling to estimate infection incidences from repeated serological tests |
| Q34552767 | An outbreak investigation of visceral leishmaniasis among residents of Dharan town, eastern Nepal, evidence for urban transmission of Leishmania donovani |
| Q40398603 | An outbreak of peritonitis caused by multidrug-resistant Salmonella Typhi in Kinshasa, Democratic Republic of Congo |
| Q56558896 | Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome? |
| Q56559462 | Antioxidant supplements for prevention of gastrointestinal cancers |
| Q56559476 | Antioxidant supplements for prevention of gastrointestinal cancers |
| Q28543757 | Arsenic exposure and outcomes of antimonial treatment in visceral leishmaniasis patients in Bihar, India: a retrospective cohort study |
| Q39350916 | Arsenic, antimony, and Leishmania: has arsenic contamination of drinking water in India led to treatment- resistant kala-azar? |
| Q39094495 | Assessment of Schistosomiasis and Soil-Transmitted Helminths prevalence in school-aged children and opportunities for integration of control in local health services in Kwilu province, the Democratic Republic of the Congo. |
| Q37726064 | Asymptomatic Leishmania infection: a new challenge for Leishmania control |
| Q36999664 | Barriers for introducing HIV testing among tuberculosis patients in Jogjakarta, Indonesia: a qualitative study |
| Q39245475 | Bayesian latent class models with conditionally dependent diagnostic tests: a case study |
| Q38134057 | Bayesian meta-analysis of diagnostic tests allowing for imperfect reference standards |
| Q21090118 | Burden of Mycobacterium ulcerans disease (Buruli ulcer) and the underreporting ratio in the territory of Songololo, Democratic Republic of Congo |
| Q34469976 | Burden of visceral leishmaniasis in villages of eastern Gedaref State, Sudan: an exhaustive cross-sectional survey |
| Q46818319 | Buruli ulcer in the health districts of the Democratic Republic of Congo from 1950 to 2013: literature review and new distribution map |
| Q56888009 | Case Report: Visceral Leishmaniasis with Paratyphi and Coinfection as a Cause of Persistent Fever in a Patient from Sudan |
| Q35575954 | Challenge of reducing perinatal mortality in rural Congo: findings of a prospective, population-based study |
| Q51800025 | Challenges in HIV and visceral Leishmania co-infection: future research directions. |
| Q33508689 | Chemical and environmental vector control as a contribution to the elimination of visceral leishmaniasis on the Indian subcontinent: cluster randomized controlled trials in Bangladesh, India and Nepal |
| Q28596498 | Clinical Research in Neglected Tropical Diseases: The Challenge of Implementing Good Clinical (Laboratory) Practices |
| Q42374602 | Clinical Research on Neglected Tropical Diseases: Challenges and Solutions |
| Q39214530 | Clinical Spectrum, Etiology, and Outcome of Neurological Disorders in the Rural Hospital of Mosango, the Democratic Republic of Congo |
| Q39185984 | Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru. |
| Q38973977 | Clinical aspects of paediatric visceral leishmaniasis in North-west Ethiopia |
| Q40380970 | Clinical risk factors for therapeutic failure in kala-azar patients treated with pentavalent antimonials in Nepal |
| Q36094248 | Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India |
| Q37698756 | Combination therapy for visceral leishmaniasis |
| Q39550574 | Combination therapy for visceral leishmaniasis |
| Q38976571 | Commentary: Substandard medicines are the priority for neglected tropical diseases |
| Q39372360 | Community participation in Aedes aegypti control: a sociological perspective on five years of research in the health area ''26 de Julio'', Havana, Cuba |
| Q40483209 | Community participation in Dengue prevention: an approach from the perspective of different social actors |
| Q61807818 | Community perception and knowledge of cystic echinococcosis in the High Atlas Mountains, Morocco |
| Q37336177 | Comparative evaluation of blood and serum samples in rapid immunochromatographic tests for visceral leishmaniasis |
| Q39098493 | Comparative evaluation of freeze-dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA-DAT/VL). |
| Q56558846 | Comparative evaluation of parasitology and serological tests in the diagnosis of visceral leishmaniasis in India: a phase III diagnostic accuracy study |
| Q43251269 | Comparative study of kala-azar vector control measures in eastern Nepal |
| Q46168331 | Comparison of operational criteria for treatment outcome in gambiense human African trypanosomiasis. |
| Q34613574 | Comparison of visceral leishmaniasis diagnostic antigens in African and Asian Leishmania donovani reveals extensive diversity and region-specific polymorphisms |
| Q38904085 | Control of cutaneous leishmaniasis caused by Leishmania major in south-eastern Morocco |
| Q28472552 | Control of visceral leishmaniasis in latin america-a systematic review |
| Q56558336 | Correction: Epidemiology and Clinical Features of Patients with Visceral Leishmaniasis Treated by an MSF Clinic in Bakool Region, Somalia, 2004–2006 |
| Q55462172 | Correction: Latent Infection with Leishmania donovani in Highly Endemic Villages in Bihar, India. |
| Q38890588 | Cost effectiveness of Aedes aegypti control programmes: participatory versus vertical |
| Q28475431 | Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent |
| Q38890583 | Cost-effectiveness of a community-based approach intertwined with a vertical Aedes control program |
| Q33776699 | Cost-effectiveness of algorithms for confirmation test of human African trypanosomiasis |
| Q38912980 | Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis. |
| Q38890578 | Costs of dengue prevention and incremental cost of dengue outbreak control in Guantanamo, Cuba |
| Q50791211 | Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India. |
| Q44162712 | Deltamethrin and permethrin residue on long-lasting insecticidal nets after 18 months of use in a visceral leishmaniasis-endemic area in Nepal |
| Q39169956 | Detection of trypanosome-specific antibodies in saliva, towards non-invasive serological diagnosis of sleeping sickness |
| Q64114796 | Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study |
| Q39553666 | Determinants of bednet ownership and use in visceral leishmaniasis-endemic areas of the Indian subcontinent |
| Q37328612 | Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon |
| Q38908097 | Development and evaluation of different PCR-based typing methods for discrimination of Leishmania donovani isolates from Nepal |
| Q38926518 | Development of an enzyme-linked immunosorbent assay to identify host-feeding preferences of Phlebotomus species (Diptera: Psychodidae) in endemic foci of visceral leishmaniasis in Nepal |
| Q36181928 | Diagnosis of Persistent Fever in the Tropics: Set of Standard Operating Procedures Used in the NIDIAG Febrile Syndrome Study |
| Q38973973 | Diagnosis of Visceral Leishmaniasis Using Peripheral Blood Microscopy in Ethiopia: A Prospective Phase-III Study of the Diagnostic Performance of Different Concentration Techniques Compared to Tissue Aspiration |
| Q35748147 | Diagnosis of neglected tropical diseases among patients with persistent digestive disorders (diarrhoea and/or abdominal pain ≥14 days): Pierrea multi-country, prospective, non-experimental case-control study |
| Q56560456 | Diagnostic PCR with Leishmania donovani specificity |
| Q34024878 | Diagnostic accuracy and feasibility of serological tests on filter paper samples for outbreak detection of T.b. gambiense human African trypanosomiasis |
| Q38968006 | Diagnostic accuracy of a new Leishmania PCR for clinical visceral leishmaniasis in Nepal and its role in diagnosis of disease |
| Q35023692 | Diagnostic accuracy of loopamp Trypanosoma brucei detection kit for diagnosis of human African trypanosomiasis in clinical samples |
| Q39279549 | Diagnostic accuracy of rK28-based immunochromatographic rapid diagnostic tests for visceral leishmaniasis: a prospective clinical cohort study in Sudan |
| Q34231781 | Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda |
| Q34085797 | Diagnostic test analyses in search of their gold standard: latent class analyses with random effects |
| Q38912945 | Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent |
| Q34395455 | Diagnostic work-up of neurological syndromes in a rural African setting: knowledge, attitudes and practices of health care providers |
| Q48507471 | Do Cryptic Reservoirs Threaten Gambiense-Sleeping Sickness Elimination? |
| Q46250257 | Do patents prevent access to drugs for HIV in developing countries? |
| Q42112349 | Domestic animals and epidemiology of visceral leishmaniasis, Nepal |
| Q37853656 | Double ethical review of North-South collaborative clinical research: hidden paternalism or real partnership? |
| Q36735774 | Drug policy for visceral leishmaniasis: a cost-effectiveness analysis |
| Q39401306 | Drug toxicity and cost as barriers to community participation in HAT control in the Democratic Republic of Congo |
| Q56558975 | Editorial: Engaging the private sector for tuberculosis control: much advocacy on a meagre evidence base |
| Q56560646 | Editorial: Geographical Information Systems (GIS), gimmick or tool for health district management? |
| Q45227661 | Editorial: Should artemisinin-based combination treatment be used in the home-based management of malaria? |
| Q56560034 | Editorial: The AIDS crisis, cost-effectiveness and academic activism |
| Q56560629 | Editorial: Zidovudine to prevent mother-to-infant HIV transmission in developing countries: any questions? |
| Q34117955 | Effect of a control project on clinical profiles and outcomes in buruli ulcer: a before/after study in Bas-Congo, Democratic Republic of Congo |
| Q39548596 | Effect of applying a treatment threshold in a population. An example of pulmonary tuberculosis in Rwanda |
| Q39355045 | Effect of untreated bed nets on blood-fed Phlebotomus argentipes in kala-azar endemic foci in Nepal and India |
| Q33528942 | Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial |
| Q38477334 | Effects of a refugee-assistance programme on host population in Guinea as measured by obstetric interventions. |
| Q84100557 | Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use |
| Q39401301 | Eflornithine is a cost-effective alternative to melarsoprol for the treatment of second-stage human West African trypanosomiasis in Caxito, Angola |
| Q61811531 | Eliminating visceral leishmaniasis in South Asia: the road ahead |
| Q30378268 | Elimination of visceral leishmaniasis in the Indian subcontinent: a comparison of predictions from three transmission models |
| Q30244956 | Elimination of visceral leishmaniasis on the Indian subcontinent |
| Q56560770 | Emergency medical aid for refugees |
| Q56560914 | Endemic juvenile hypothyroidism in a severe endemic goitre area of Sudan |
| Q33305361 | Epidemiology and clinical features of patients with visceral leishmaniasis treated by an MSF clinic in Bakool region, Somalia, 2004-2006 |
| Q46789191 | Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal |
| Q31166912 | Epidemiology of visceral leishmaniasis in Algeria: an update |
| Q43187053 | Erratum to: Diagnosis of neglected tropical diseases among patients with persistent digestive disorders (diarrhoea and/or abdominal pain ≥14 days): a multi-country, prospective, non-experimental case-control study |
| Q47894577 | European Union's research policy: a moving target? |
| Q40532228 | Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal |
| Q40373398 | Evaluation of latent class analysis and decision thresholds to guide the diagnosis of pediatric tuberculosis in a Rwandan reference hospital |
| Q51836470 | Evaluation of leishmanin skin test in Indian visceral leishmaniasis. |
| Q38496709 | Evidence-based vector control? Improving the quality of vector control trials |
| Q28551055 | Evolutionary genomics of epidemic visceral leishmaniasis in the Indian subcontinent |
| Q30827410 | Experiences and Lessons from a Multicountry NIDIAG Study on Persistent Digestive Disorders in the Tropics |
| Q46733639 | Exploring HIV risk perception and behaviour in the context of antiretroviral treatment: results from a township household survey |
| Q34129087 | Exposure to Phlebotomus argentipes (Diptera, Psychodidae, Phlebotominae) sand flies in rural areas of Bihar, India: the role of housing conditions |
| Q28306178 | Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure |
| Q21132005 | Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia |
| Q35112184 | Fatal Chromobacterium violaceum bacteraemia in rural Bandundu, Democratic Republic of the Congo |
| Q35898499 | Feasibility of eliminating visceral leishmaniasis from the Indian subcontinent: explorations with a set of deterministic age-structured transmission models |
| Q50957711 | Field evaluation of FD-DAT, rK39 dipstick and KATEX (urine latex agglutination) for diagnosis of visceral leishmaniasis in northwest Ethiopia. |
| Q46186865 | Field evaluation of latex agglutination test for detecting urinary antigens in visceral leishmaniasis in Sudan. |
| Q51956351 | Field validity, reproducibility and feasibility of diagnostic tests for visceral leishmaniasis in rural Nepal. |
| Q56560687 | Food rations for refugees |
| Q35345427 | From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study |
| Q53588405 | Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia. |
| Q34017586 | Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent |
| Q39386623 | Governance and Standards in International Clinical Research: The Role of Transnational Consortia |
| Q38083295 | HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals |
| Q34309812 | Health & Demographic Surveillance System profile: the Muzaffarpur-TMRC Health and Demographic Surveillance System |
| Q39052722 | Health care-seeking behaviour and diagnostic delays for Human African Trypanosomiasis in the Democratic Republic of the Congo |
| Q37009244 | High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo |
| Q28539053 | High parasitological failure rate of visceral leishmaniasis to sodium stibogluconate among HIV co-infected adults in Ethiopia |
| Q34734114 | High prevalence of Schistosoma mansoni in six health areas of - Kasansa health zone, Democratic Republic of the Congo: short report |
| Q46387236 | Household cost-of-illness of visceral leishmaniasis in Bihar, India |
| Q38912955 | How better drugs could change kala-azar control. Lessons from a cost-effectiveness analysis. |
| Q35351899 | How do health care providers deal with kala-azar in the Indian subcontinent? |
| Q34075053 | How far are we from visceral leishmaniasis elimination in Bangladesh? An assessment of epidemiological surveillance data |
| Q51760220 | How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness. |
| Q29056943 | Human African Trypanosomiasis in the Democratic Republic of the Congo: A Looming Emergency? |
| Q39401316 | Human African trypanosomiasis amongst urban residents in Kinshasa: a case-control study |
| Q56556891 | Human African trypanosomiasis diagnosis in first-line health services of endemic countries, a systematic review |
| Q37302722 | Human African trypanosomiasis in a rural community, Democratic Republic of Congo |
| Q34500882 | Human african trypanosomiasis diagnosis in first-line health services of endemic countries, a systematic review |
| Q34395015 | IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test |
| Q37191345 | Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials |
| Q46658265 | Impact of a mass vaccination campaign against a meningitis epidemic in a refugee camp |
| Q35597666 | Impact of the use of a rapid diagnostic test for visceral leishmaniasis on clinical practice in Ethiopia: a retrospective study |
| Q44379606 | Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment |
| Q45012267 | Incidence of surgical-site infections and the validity of the National Nosocomial Infections Surveillance System risk index in a general surgical ward in Santa Cruz, Bolivia |
| Q31032931 | Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study |
| Q28285948 | Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance |
| Q46523934 | Infection rates with Leishmania donovani and Mycobacterium tuberculosis in a village in eastern Sudan |
| Q33737651 | Insecticide susceptibility of Phlebotomus argentipes in visceral leishmaniasis endemic districts in India and Nepal |
| Q56559732 | Integrating tuberculosis and HIV care in the primary care setting in South Africa |
| Q64296317 | Integration of Human African Trypanosomiasis Control Activities into Primary Health Services in the Democratic Republic of the Congo: A Qualitative Study of Stakeholder Perceptions |
| Q39254761 | Integration of diagnosis and treatment of sleeping sickness in primary healthcare facilities in the Democratic Republic of the Congo |
| Q28475151 | Interactions between Global Health Initiatives and country health systems: the case of a neglected tropical diseases control program in Mali |
| Q28477803 | Interferon-gamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept study |
| Q38069277 | Intersectoral collaboration between the medical and veterinary professions in low-resource societies: The role of research and training institutions |
| Q39427637 | Intersectoral coordination in Aedes aegypti control. A pilot project in Havana City, Cuba |
| Q56559179 | Iodine deficiency mitigates growth retardation and osteopenia in selenium-deficient rats |
| Q56558630 | Iodine nutritional status in Tibet |
| Q36394552 | It is time to revise the international Good Clinical Practices guidelines: recommendations from non-commercial North-South collaborative trials |
| Q28345057 | Kashin-Beck disease and iodine deficiency in Tibet |
| Q34067646 | Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status |
| Q38912962 | Latent class analysis permits unbiased estimates of the validity of DAT for the diagnosis of visceral leishmaniasis |
| Q34607966 | Latent infection with Leishmania donovani in highly endemic villages in Bihar, India |
| Q40355083 | Lay perceptions of kala-azar, mosquitoes and bed nets in Bihar, India |
| Q37080535 | Leishmaniases in the Mediterranean in the era of molecular epidemiology |
| Q34526230 | Leishmaniasis direct agglutination test: using pictorials as training materials to reduce inter-reader variability and improve accuracy |
| Q36581549 | Liposomal amphotericin B for the treatment of visceral leishmaniasis |
| Q60725340 | List of Contributors |
| Q47705421 | Long-lasting insecticidal nets fail at household level to reduce abundance of sandfly vector Phlebotomus argentipes in treated houses in Bihar (India). |
| Q35347114 | Long-lasting insecticidal nets to prevent visceral leishmaniasis in the Indian subcontinent; methodological lessons learned from a cluster randomised controlled trial |
| Q34445696 | Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial |
| Q56559889 | Low back pain in rural Tibet |
| Q34443655 | Management of visceral leishmaniasis in rural primary health care services in Bihar, India |
| Q56560726 | Managing diabetes mellitus in a Lebanese primary care centre. Working towards change |
| Q33817576 | Measurement of recent exposure to Phlebotomus argentipes, the vector of Indian visceral Leishmaniasis, by using human antibody responses to sand fly saliva |
| Q56560342 | Meningococcal immunisation in Ghana |
| Q35156774 | Model-based investigations of different vector-related intervention strategies to eliminate visceral leishmaniasis on the Indian subcontinent |
| Q42272391 | Molecular and serological markers of Leishmania donovani infection in healthy individuals from endemic areas of Bihar, India |
| Q35154324 | Monitoring drug effectiveness in kala-azar in Bihar, India: cost and feasibility of periodic random surveys vs. a health service-based reporting system |
| Q28537853 | Multi drug resistant tuberculosis in Mosango, a rural area in the Democratic Republic of Congo |
| Q38912965 | Multi-centre evaluation of repeatability and reproducibility of the direct agglutination test for visceral leishmaniasis |
| Q35576073 | Mycobacterium ulcerans infection (Buruli ulcer) on the face: a comparative analysis of 13 clinically suspected cases from the Democratic Republic of Congo |
| Q56556804 | NTD control and health system strengthening |
| Q38908100 | Natural infection of Phlebotomus argentipes with Leishmania and other trypanosomatids in a visceral leishmaniasis endemic region of Nepal |
| Q39169946 | Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis |
| Q38912969 | Operational validation of the direct agglutination test for diagnosis of visceral leishmaniasis. |
| Q58550365 | Outbreak of Tuberculosis and Multidrug-Resistant Tuberculosis, Mbuji-Mayi Central Prison, Democratic Republic of the Congo |
| Q38908103 | PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-Azar |
| Q35075748 | Perceptions of health, health care and community-oriented health interventions in poor urban communities of Kinshasa, Democratic Republic of Congo |
| Q34738791 | Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India |
| Q27004352 | Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests |
| Q39355027 | Phlebotomus argentipes seasonal patterns in India and Nepal |
| Q84836315 | Poor-quality medical products: time to address substandards, not only counterfeits |
| Q33312431 | Population preference of net texture prior to bed net trial in Kala-Azar-endemic areas |
| Q56556770 | Post-kala-azar dermal leishmaniasis (PKDL) in visceral leishmaniasis-endemic communities in Bihar, India |
| Q34113819 | Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000-2010) |
| Q39467473 | Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India |
| Q47845248 | Present situation of vector-control management in Bangladesh: a wake up call |
| Q56560540 | Preventing HIV-1: lessons from Mwanza and Rakai |
| Q39547746 | Primary health care vs. emergency medical assistance: a conceptual framework |
| Q33303605 | Private practitioners and tuberculosis case detection in Jogjakarta, Indonesia: actual role and potential |
| Q34058850 | Pseudo-outbreak of pre-extensively drug-resistant (Pre-XDR) tuberculosis in Kinshasa: collateral damage caused by false detection of fluoroquinolone resistance by GenoType MTBDRsl |
| Q54951341 | Psychosocial burden of localised cutaneous Leishmaniasis: a scoping review. |
| Q37740950 | Psychosocial impact of scars due to cutaneous leishmaniasis on high school students in Errachidia province, Morocco |
| Q36181966 | Rapid Diagnostic Tests for Neglected Infectious Diseases: Case Study Highlights Need for Customer Awareness and Postmarket Surveillance |
| Q38102421 | Rapid diagnostic tests for neurological infections in central Africa |
| Q24236732 | Rapid diagnostic tests for visceral leishmaniasis |
| Q24193697 | Rapid tests for the diagnosis of visceral leishmaniasis in patients with suspected disease |
| Q36017761 | Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood |
| Q34194205 | Recurrence in tuberculosis: relapse or reinfection? |
| Q64073582 | Recurrent Cholera Outbreaks, Democratic Republic of the Congo, 2008-2017 |
| Q46958566 | Refugee relief rations |
| Q86939283 | Reply to Arya and Agarwal |
| Q56556720 | Reply to Das |
| Q54121571 | Research capacity strengthening in the DRC. |
| Q33737636 | Research priorities for neglected infectious diseases in Latin America and the Caribbean region |
| Q39355008 | Residual activity and integrity of PermaNet® 2.0 after 24 months of household use in a community randomised trial of long lasting insecticidal nets against visceral leishmaniasis in India and Nepal |
| Q33631299 | Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease). |
| Q39329286 | Retrospective Quarterly Cohort Monitoring for patients with Visceral Leishmaniasis in the Indian subcontinent: outcomes of a pilot project |
| Q38736545 | Risk Factors associated with defaulting from visceral leishmaniasis treatment: analysis under routine programme conditions in Bihar, India. |
| Q37538994 | Risk factors for visceral leishmaniasis and asymptomatic Leishmania donovani infection in India and Nepal |
| Q33955509 | Risk factors for visceral leishmaniasis in India: further evidence on the role of domestic animals |
| Q34207302 | Selenium and iodine supplementation of rural Tibetan children affected by Kashin-Beck osteoarthropathy |
| Q35983488 | Sensitivity and Specificity of a Prototype Rapid Diagnostic Test for the Detection of Trypanosoma brucei gambiense Infection: A Multi-centric Prospective Study |
| Q38928117 | Sensitivity and specificity of HAT Sero-K-SeT, a rapid diagnostic test for serodiagnosis of sleeping sickness caused by Trypanosoma brucei gambiense: a case-control study |
| Q56557746 | Serological markers for Leishmania donovani infection in Nepal: agreement between direct agglutination test and rK39 ELISA |
| Q34024120 | Serological markers of sand fly exposure to evaluate insecticidal nets against visceral leishmaniasis in India and Nepal: a cluster-randomized trial |
| Q30233740 | Short communication: dengue serotype 2 subtype III ('Jamaica') epidemic in Santa Cruz, Bolivia |
| Q28478935 | Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo |
| Q35109189 | Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis |
| Q36294069 | Single locus genotyping to track Leishmania donovani in the Indian subcontinent: Application in Nepal. |
| Q46487230 | Sleeping sickness in the region of the town of Kinshasa: a retrospective analysis during the surveillance period 1996-2000 |
| Q37811110 | Socio-economic aspects of neglected diseases: sleeping sickness and visceral leishmaniasis |
| Q44667232 | Sodium stibogluconate cardiotoxicity and safety of generics |
| Q45194877 | Spatial analysis of Leishmania donovani exposure in humans and domestic animals in a recent kala azar focus in Nepal |
| Q46193871 | Spatial variation of risk for pigs to contract trypanosomosis in farms situated in the peri-urban area of Kinshasa |
| Q35881241 | Sponsorship in non-commercial clinical trials: definitions, challenges and the role of Good Clinical Practices guidelines |
| Q31161304 | Spread of vector-borne diseases and neglect of Leishmaniasis, Europe |
| Q37509590 | Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal |
| Q39204003 | Strong general health care systems: a prerequisite to reach global tuberculosis control targets |
| Q41653401 | Surveillance of the nutritional status of the population in Kinshasa, Zaire (1991-1994) |
| Q53486274 | The 5th Amendment of the Declaration of Helsinki: implications for medical research in developing countries. |
| Q36181972 | The Art of Writing and Implementing Standard Operating Procedures (SOPs) for Laboratories in Low-Resource Settings: Review of Guidelines and Best Practices |
| Q36181950 | The Challenges of Conducting Clinical Research on Neglected Tropical Diseases in Remote Endemic Areas in Sudan |
| Q56557824 | The burden of visceral leishmaniasis in South Asia |
| Q35598976 | The challenge of Trypanosoma brucei gambiense sleeping sickness diagnosis outside Africa |
| Q50775538 | The economic burden of visceral leishmaniasis for households in Nepal. |
| Q37372627 | The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs. |
| Q39401311 | The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo |
| Q51701298 | The efficacy of indoor CDC light traps for collecting the sandfly Phlebotomus argentipes, vector of Leishmania donovani. |
| Q46363705 | The efficiency of different detection strategies of human African trypanosomiasis by T. b. gambiense |
| Q51696250 | The epidemiology of Leishmania donovani infection in high transmission foci in India. |
| Q58671794 | The ethics of non-inferiority trials |
| Q56558766 | The ethics of non-inferiority trials |
| Q34613587 | The household costs of visceral leishmaniasis care in south-eastern Nepal |
| Q33592697 | The incremental cost-effectiveness of engaging private practitioners to refer tuberculosis suspects to DOTS services in Jogjakarta, Indonesia |
| Q56559112 | The need for strong general health services in India and elsewhere |
| Q44105938 | The origin of Ebola: Biomedical approach versus popular interpretations in Macenta, Guinea |
| Q38912940 | The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India |
| Q38912975 | The potential of latent class analysis in diagnostic test validation for canine Leishmania infantum infection |
| Q39358066 | The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region |
| Q56560072 | Therapeutic feeding centres for severe malnutrition |
| Q39135105 | Therapeutic itineraries of patients with ulcerated forms of Mycobacterium ulcerans (Buruli ulcer) disease in a rural health zone in the Democratic Republic of Congo |
| Q34037277 | Through Mintzberg's glasses: a fresh look at the organization of ministries of health. |
| Q39527729 | Towards active community participation in dengue vector control: results from action research in Santiago de Cuba, Cuba |
| Q36094815 | Transmission Dynamics of Visceral Leishmaniasis in the Indian Subcontinent - A Systematic Literature Review |
| Q28634559 | Transmission of Leishmania donovani in the Hills of Eastern Nepal, an Outbreak Investigation in Okhaldhunga and Bhojpur Districts |
| Q35946968 | Treatment failure related to intrathecal immunoglobulin M (IgM) synthesis, cerebrospinal fluid IgM, and interleukin-10 in patients with hemolymphatic-stage sleeping sickness |
| Q56555998 | Treatment of visceral leishmaniasis: pitfalls and stewardship |
| Q34342721 | Treatment outcomes for human African Trypanosomiasis in the Democratic Republic of the Congo: analysis of routine program data from the world's largest sleeping sickness control program |
| Q35847379 | Trypanosomiasis control, Democratic Republic of Congo, 1993-2003 |
| Q38965218 | Trypanosomiasis in Kinshasa: distribution of the vector, Glossina fuscipes quanzensis, and risk of transmission in the peri-urban area |
| Q36508569 | Understanding the transmission dynamics of Leishmania donovani to provide robust evidence for interventions to eliminate visceral leishmaniasis in Bihar, India |
| Q56556782 | Universal access to quality medicines: prioritisation of a-priori solutions |
| Q39508351 | Urbanisation of yellow fever in Santa Cruz, Bolivia |
| Q28548702 | Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study |
| Q34787485 | Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence? |
| Q36289626 | Vector control interventions for visceral leishmaniasis elimination initiative in South Asia, 2005-2010. |
| Q38914896 | Viewpoint: filovirus haemorrhagic fever outbreaks: much ado about nothing? |
| Q36557152 | Village health workers in Bihar, India: an untapped resource in the struggle against kala-azar |
| Q60956585 | Visceral Leishmaniasis IgG1 Rapid Monitoring of Cure vs. Relapse, and Potential for Diagnosis of Post Kala-Azar Dermal Leishmaniasis |
| Q24290704 | Visceral Leishmaniasis and HIV coinfection in East Africa |
| Q34043521 | Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent? |
| Q34115722 | Visceral leishmaniasis control: a public health perspective |
| Q33401607 | Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy |
| Q33843296 | Visceral leishmaniasis in Muzaffarpur district, Bihar, India from 1990 to 2008. |
| Q30235354 | Visceral leishmaniasis in Somalia: A review of epidemiology and access to care |
| Q36318398 | Visceral leishmaniasis in rural bihar, India |
| Q39435843 | Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors |
| Q34091527 | Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control |
| Q52744493 | Visceral leishmaniasis treatment in the Indian subcontinent: how to reach the most vulnerable. |
| Q34768663 | Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda |
| Q29038941 | Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? |
| Q39268269 | Vitamin D deficiency and hyperparathyroidism in relation to ethnicity: a cross-sectional survey in healthy adults |
| Q56559607 | Voluntary counseling and HIV testing for pregnant women in the Kassena-Nankana district of northern Ghana: Is couple counseling the way forward? |
| Q33345672 | Voluntary counselling and testing uptake and HIV prevalence among tuberculosis patients in Jogjakarta, Indonesia |
| Q55068626 | Wartime colon injuries: primary repair or colostomy? |
| Q56560854 | What should be done in acute emergencies? |
| Q56886534 | Where there is no brain imaging: Safety and diagnostic value of lumbar puncture in patients with neurological disorders in a rural hospital of Central Africa |
| Q54961274 | Why miltefosine-a life-saving drug for leishmaniasis-is unavailable to people who need it the most. |
| Q56557121 | Will visceral leishmaniasis be eliminated from Nepal? A review of recent (1994-2006) control efforts |
| Q52646099 | [Community participation in the control of Aedes aegypti: opinions of the population in one section of Havana, Cuba]. |
| Q56560306 | [Early neonatal mortality at the gynecological-obstetrical hospital of Hanoi, Vietnam] |
| Q56560741 | [Epidemic outbreak of dengue virus 2/Jamaica genotype in Bolivia] |
| Q54120045 | [Validity, cost and feasibility of the mAECT and CTC confirmation tests after diagnosis of African of sleeping sickness] |